Compugen (CGEN) Total Current Liabilities (2009 - 2026)
Compugen (CGEN) reported Total Current Liabilities of $22.0 million for Q1 2026, up 4.97% on a YoY basis from $21.0 million in Q1 2025, and down 2.36% sequentially from $22.6 million in Q4 2025.
Compugen (CGEN) Total Current Liabilities (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Total Current Liabilities data on file, last reported at $22.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 4.97% year-over-year to $22.0 million; the trailing twelve-month figure through Mar 2026 stood at $22.0 million (up 4.97% YoY), and the FY2025 full-year result was $22.6 million, up 11.95% from the prior year.
- Total Current Liabilities fell to $22.0 million in Q1 2026, from $22.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $27.8 million in Q3 2024 to a low of $10.4 million in Q3 2023.
- A 5-year average of $18.7 million and a median of $20.3 million in 2025 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities tumbled 31.74% in 2023 and soared 167.55% in 2024, its largest moves.
- Tracing CGEN's Total Current Liabilities over 5 years: stood at $11.9 million in 2022, then surged by 120.37% to $26.3 million in 2023, then retreated by 23.25% to $20.2 million in 2024, then gained by 11.95% to $22.6 million in 2025, then decreased by 2.36% to $22.0 million in 2026.
- Business Quant data shows CGEN's Total Current Liabilities at $22.0 million in Q1 2026, $22.6 million in Q4 2025, and $20.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 22.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.04 Mn |
| Dec 31, 2025 | 22.57 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 20.58 Mn |
| Mar 31, 2025 | 20.99 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 27.76 Mn |
| Jun 30, 2024 | 24.77 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 26.27 Mn |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 10.80 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 14.77 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 15.70 Mn |
| Dec 31, 2021 | 17.10 Mn |
| Sep 30, 2021 | 15.26 Mn |
| Jun 30, 2021 | 11.85 Mn |